Phentermine
Colitis, Ulcerative
University of California, San DiegoSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Colitis, Ulcerative cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PEFICITINIB Janssen Research & Development, LLC | Phase 2 | B |
PREDNISOLONE SODIUM METASULFOBENZOATE Prometheus Laboratories | Phase 2 | B |
Topamax University of California, San Diego | Phase 2 | CCC |
Tamuzimod Oppilan Pharma Ltd | Phase 2 | CCC |
gsk3888130b GlaxoSmithKline | Phase 1 | CC |
Same molecule, other indications
Phentermine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →